A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study

• Hauptverfasser: Oriol Alberto Rangel-Zuñiga (VerfasserIn), Cristina Vals-Delgado (VerfasserIn), Juan Francisco Alcala-Diaz (VerfasserIn), Gracia M. Quintana-Navarro (VerfasserIn), Yelizaveta Krylova (VerfasserIn), Ana Leon-Acuña (VerfasserIn), Raul Miguel Luque (VerfasserIn), Francisco Gomez-Delgado (VerfasserIn), Javier Delgado-Lista (VerfasserIn), Jose Maria Ordovas (VerfasserIn), Pablo Perez-Martinez (VerfasserIn), Antonio Camargo (VerfasserIn), Jose Lopez-Miranda (VerfasserIn)
• Format: Buch
• Veröffentlicht: Elsevier, 2021-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

MicroRNAs (miRNAs) regulate the expression of genes associated with the development of diseases, including type 2 diabetes mellitus (T2DM). However, the use of miRNAs to predict T2DM remission has been poorly studied. Therefore, we aimed to investigate whether circulating miRNAs could be used to pre...